What is a stock summary page? Click here for an overview.
Business Description
Diagnosticos da America SA
ISIN : BRDASAACNOR1
Description
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.64 | |||||
| Debt-to-EBITDA | 6.54 | |||||
| Interest Coverage | 0.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.71 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.6 | |||||
| 3-Year EBITDA Growth Rate | -5.8 | |||||
| 3-Year EPS without NRI Growth Rate | -19.4 | |||||
| 3-Year Book Growth Rate | -22.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -9.87 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.04 | |||||
| 9-Day RSI | 47.44 | |||||
| 14-Day RSI | 47.98 | |||||
| 3-1 Month Momentum % | 0.53 | |||||
| 6-1 Month Momentum % | -36.45 | |||||
| 12-1 Month Momentum % | -56.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 15.54 | |||||
| Days Sales Outstanding | 110.71 | |||||
| Days Payable | 45.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.6 | |||||
| Shareholder Yield % | -78.86 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.37 | |||||
| Operating Margin % | 6.41 | |||||
| Net Margin % | -7.83 | |||||
| FCF Margin % | -3.33 | |||||
| ROE % | -15.69 | |||||
| ROA % | -4.41 | |||||
| ROIC % | 4.98 | |||||
| 3-Year ROIIC % | 65.47 | |||||
| ROC (Joel Greenblatt) % | 7.32 | |||||
| ROCE % | 2.88 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.55 | |||||
| PS Ratio | 0.1 | |||||
| PB Ratio | 0.29 | |||||
| EV-to-EBIT | 21.53 | |||||
| EV-to-Forward-EBIT | 10.17 | |||||
| EV-to-EBITDA | 6.73 | |||||
| EV-to-Forward-EBITDA | 6.11 | |||||
| EV-to-Revenue | 0.87 | |||||
| EV-to-Forward-Revenue | 1.1 | |||||
| EV-to-FCF | -26.21 | |||||
| Price-to-GF-Value | 0.24 | |||||
| Price-to-Projected-FCF | 1.09 | |||||
| Price-to-Median-PS-Value | 0.05 | |||||
| Earnings Yield (Greenblatt) % | 4.64 | |||||
| FCF Yield % | -22.45 | |||||
| Forward Rate of Return (Yacktman) % | -35.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diagnosticos da America SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 15,322.079 | ||
| EPS (TTM) (R$) | -1.157 | ||
| Beta | 1.59 | ||
| 3-Year Sharpe Ratio | -1.42 | ||
| 3-Year Sortino Ratio | -1.54 | ||
| Volatility % | 41.46 | ||
| 14-Day RSI | 47.98 | ||
| 14-Day ATR (R$) | 0.092797 | ||
| 20-Day SMA (R$) | 1.8835 | ||
| 12-1 Month Momentum % | -56.42 | ||
| 52-Week Range (R$) | 1.6 - 5.29 | ||
| Shares Outstanding (Mil) | 1,249.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diagnosticos da America SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diagnosticos da America SA Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diagnosticos da America SA Frequently Asked Questions
What is Diagnosticos da America SA(BSP:DASA3)'s stock price today?
The current price of BSP:DASA3 is R$1.82. The 52 week high of BSP:DASA3 is R$5.29 and 52 week low is R$1.60.
When is next earnings date of Diagnosticos da America SA(BSP:DASA3)?
The next earnings date of Diagnosticos da America SA(BSP:DASA3) is .
Does Diagnosticos da America SA(BSP:DASA3) pay dividends? If so, how much?
Diagnosticos da America SA(BSP:DASA3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers